Sector |
|
Compare with Sector peers |
Industry |
|
Compare with Industry peers |
Website | http://www.suven.com | |
Market Cap | 1,349.88 Cr. | |
Enterprise Value(EV) | 1,380.67 Cr. | 2022-09 |
Financial Indicators | ||
---|---|---|
Earnings per share (EPS) | -4.31 | Trailing Twelve Months Ending 2022-09 |
Price-Earning Ratio (PE) | - | Trailing Twelve Months Ending 2022-09 |
Industry PE | 32.90 | Trailing Twelve Months Ending 2022-09 |
Book Value / Share | 20.92 | Trailing Twelve Months Ending 2022-09 |
Price to Book Value | 2.95 | Calculated using Price: 61.80 |
Dividend Yield | 0.00 | Period Ending 2022-03 |
No. of Shares Subscribed | 21.81 Cr. | 218,073,717 Shares |
FaceValue | 1 | |
Company Profile | ||
Suven Life Sciences was promoted by Mrs. and Mr. Venkat Jasti in 1989, as a Private Limited Company. Later it was converted into a Public Limited Company in January 1995. |
1 Day |
|
-3.74% |
1 Week |
|
-5.58% |
1 Month |
|
-8.31% |
3 Month |
|
-0.24% |
6 Month |
|
-4.17% |
1 Year |
|
-24.25% |
2 Year |
|
-7.98% |
5 Year |
|
-68.81% |
10 Year |
|
+154.53% |
9 years | 2008-03 | 2015-03 | 2016-03 | 2017-03 | 2018-03 | 2019-03 | 2020-03 | 2021-03 | 2022-03 | |
Return on Equity (%) | 8.04 | 32.91 | 12.50 | 13.81 | 17.25 | -4.75 | -49.27 | -67.29 | -145.90 | |
Return on Capital Employed (%) | 7.51 | 37.93 | 15.43 | 18.19 | 26.01 | 0.40 | -54.67 | -60.09 | -117.81 | |
Return on Assets (%) | 4.49 | 22.38 | 8.87 | 9.97 | 12.84 | -3.31 | -27.07 | -28.99 | -57.51 |
Particulars | 9 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09* Rs. Cr. |
Shh. Funds | 559 | 595 | 667 | 767 | 239 | 143 | 108 | 96 | 56 | |
Non Curr. Liab. | 86 | 41 | 28 | 30 | 25 | 12 | 5 | 4 | 4 | |
Curr. Liab. | 127 | 211 | 208 | 226 | 157 | 120 | 110 | 102 | 61 | |
Minority Int. | ||||||||||
Equity & Liab. | 773 | 846 | 903 | 1,023 | 421 | 275 | 222 | 202 | 121 | |
Non Curr. Assets | 291 | 319 | 322 | 350 | 22 | 116 | 26 | 41 | 40 | |
Curr. Assets | 477 | 528 | 581 | 674 | 398 | 160 | 197 | 160 | 80 | |
Misc. Exp. not W/O | 5 | |||||||||
Total Assets | 773 | 846 | 903 | 1,023 | 421 | 275 | 222 | 202 | 121 |
Particulars | 10 years | 2008-03 Rs. Cr. | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. | 2022-09 Rs. Cr. TTM |
Net Sales | 117 | 521 | 500 | 544 | 625 | 286 | 14 | 13 | 12 | 17 | |
Other Income | 3 | 9 | 20 | 21 | 23 | 27 | 14 | 8 | 5 | 1 | |
Total Income | 120 | 529 | 519 | 565 | 649 | 313 | 28 | 21 | 17 | 17 | |
Total Expenditure | -105 | -361 | -398 | -414 | -424 | -297 | -130 | -93 | -134 | -112 | |
PBIDT | 16 | 168 | 121 | 150 | 225 | 16 | -102 | -72 | -117 | -94 | |
Interest | -5 | -5 | -6 | -6 | -5 | -2 | -1 | -1 | -1 | 0 | |
Depreciation | -4 | -12 | -18 | -21 | -25 | -14 | -4 | -4 | -4 | -6 | |
Taxation | 2 | -43 | -26 | -36 | -72 | -24 | 12 | 5 | |||
Exceptional Items | 6 | ||||||||||
PAT | 8 | 109 | 72 | 87 | 124 | -24 | -94 | -72 | -122 | -94 | |
Minority Interest | |||||||||||
Share Associate | |||||||||||
Other Related Items | |||||||||||
Consolidated Net Profit | 8 | 109 | 72 | 87 | 124 | -24 | -94 | -72 | -122 | -94 | |
Adjusted EPS | 1 | 8 | 5 | 6 | 9 | -2 | -7 | -5 | -8 | -6 |
Particulars | 8 years | 2015-03 Rs. Cr. | 2016-03 Rs. Cr. | 2017-03 Rs. Cr. | 2018-03 Rs. Cr. | 2019-03 Rs. Cr. | 2020-03 Rs. Cr. | 2021-03 Rs. Cr. | 2022-03 Rs. Cr. |
Cash Fr. Operatn. | 143 | 68 | 109 | 70 | -53 | -135 | -96 | -128 | |
Cash Fr. Inv. | -110 | -39 | -311 | -1 | 37 | 146 | 56 | -22 | |
Cash Fr. Finan. | 179 | -68 | -30 | -52 | 5 | 3 | 35 | 146 | |
Net Change | 212 | -39 | -232 | 17 | -11 | 14 | -5 | -4 | |
Cash & Cash Eqvt | 279 | 241 | 9 | 26 | 0 | 15 | 9 | 5 |
Wed, 25 Jan 2023
Board Meeting Intimation for Intimation Of Board Meeting Of The Company To Be Held On Thursday February 02 2023 - Reg. SUVEN LIFE SCIENCES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 02/02/2023 inter alia to consider and approve With reference to above subject pursuant to Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015 please note that a Meeting of the Board of Directors of the Company will be held on Thursday February 02 2023 at 11:30 a.m. at the Registered Office of the Company at SDE Serene Chambers 6th Floor Road No 5 Banjara Hills Hyderabad-500034 to consider among other things inter alia and take on record the following matter(s): To consider and approve the Un-audited Financial Results (Standalone and Consolidated) of the Company under Ind AS for the quarter ended December 31 2022 and related matters.Please further note that TRADING WINDOW for dealing in the securities of the company is already closed from January 01 2023 as per PIT Code of the Company. Trading window will be opened from February 06 2023. |
Fri, 06 Jan 2023
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 This is to inform that the details of securities dematerialized/ rematerialized during the quarter ended December 31 2022 as required under Regulation 74(5) of SEBI (Depositories and Participants) Regulations 2018 have been furnished by KFin Technologies Limited Registrar & Transfer Agent (RTA) of the Company to the stock exchanges where the shares of the Company are listed. Letters confirming this from KFin Technologies Limited dated January 06 2023 are enclosed for your reference. |
Fri, 30 Dec 2022
Closure of Trading Window We wish to inform that the "Trading Window" for dealing in the securities of the Company will be closed for the Designated Persons their immediate relatives covered under the said Code of the Company from January 01 2023 and the same will remain closed till 48 hours after the declaration of Financial Results for the quarter ending December 31 2022 to the public in terms of the Code of Conduct of the Company under the SEBI (Prohibition of Insider Trading) Regulations 2015. |
Fri, 27 Jan 2023 |
|
|
|
|
|